Showing results (441-450 of 754) with videos related to

Sort By:
Pageof 76
Radiology|November 1, 1985
Pediatric liver transplantation. Part II. Diagnostic imaging in postoperative managementR Dominguez, L W Young, J Ledesma-Medina, et al.
Transplantation|August 27, 1997
Pregnancy after liver transplantation under tacrolimusA Jain, R Venkataramanan, J J Fung, et al.
Pediatrics|October 1, 1986
Evaluation of the pediatric patient for liver transplantationB J Zitelli, J J Malatack, J C Gartner, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2009
A prospective study of intrafraction prostate motion in the prone vs. supine positionRichard B Wilder, Lucy Chittenden, Albert V Mesa, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 23, 2015
Dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with high-dose-rate brachytherapy for large prostate volumesGeorge Yang, Tobin J Strom, Richard B Wilder, et al.
Cancer|September 26, 2001
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphomaC S Ha, S L Tucker, A I Blanco, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Patient Education and Counseling|October 1, 1994
A comparison of education methods and their impact on behavioral change in patients with hyperlipidemiaA S Dobs, R B Masters, L Rajaram, et al.
Cancer|June 20, 2001
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphomaR B Wilder, M A Rodriguez, C S Ha, et al.
Kidney International|June 6, 2003
Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78ArgMasahide Yazaki, Juris J Liepnieks, Mark S Barats, et al.
Pageof 76